Immunobiology of Toll‐like receptors: Emerging trends
- 1 August 2006
- journal article
- review article
- Published by Wiley in Immunology & Cell Biology
- Vol. 84 (4), 333-341
- https://doi.org/10.1111/j.1440-1711.2006.01444.x
Abstract
Immunology and Cell Biology focuses on the general functioning of the immune system in its broadest sense, with a particular emphasis on its cell biology. Areas that are covered include but are not limited to: Cellular immunology, Innate and adaptive immunity, Immune responses to pathogens,Tumour immunology,Immunopathology, Immunotherapy, Immunogenetics, Immunological studies in humans and model organisms (including mouse, rat, Drosophila etc)Funding Information
- National Institutes of Health (R01HL070885, R01HL073349)
This publication has 122 references indexed in Scilit:
- A molecule that is associated with Toll-like receptor 4 and regulates its cell surface expressionBiochemical and Biophysical Research Communications, 2006
- Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNANature Immunology, 2005
- Role of Toll-Like Receptor–Driven Innate Immunity in Thoracic Organ TransplantationThe Journal of Heart and Lung Transplantation, 2005
- Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral responseNature, 2005
- Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6Nature, 2005
- Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signalingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependentCellular Microbiology, 2005
- Re-examination of the Role of Suppressor of Cytokine Signaling 1 (SOCS1) in the Regulation of Toll-like Receptor SignalingPublished by Elsevier BV ,2004
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse modelVaccine, 2004